Peloton Therapeutics

Developer of small molecule therapeutics to treat kidney cancer

placeDallas, Texas, United States calendar_todayFounded 2010 groups62 employees language pelotontherapeutics.com

Registered entities

Investor mix

16 investors on record; lead investors include The Column Group, Nextech Invest, RA Capital Management; 2 have since exited.

Investor typeCountShare
Venture capital744%
Private equity425%
Other / undisclosed531%
Coming soon